Aug 10, 2026

Kavak's Playbook for Rebuilding a Company Around AI

Alejandro Maza Ayala, Chief Product & AI Officer at Kavak, details how the used-car marketplace transformed into an AI-native company. He explains the 'agent-per-customer' architecture, where individual agents handle 96% of customer interactions and 95% of transactions, outperforming human teams in sales (2.1x better conversion) and even acting as an 'AI CEO' that boosted profits by 50% in an experimental city. The discussion covers the need to redesign company structures, the importance of robust evaluations, and how a 'Jedi Academy' trains all employees, from executives to mechanics, to build and collaborate with AI agents. Ayala argues for 'creative destruction,' suggesting that true AI leverage comes from rebuilding organizations from the ground up, rather than incremental adoption, presenting a massive opportunity for new founders.

Aug 08, 2026

Why Robotics Still Isn't Solved - But Could Be Soon | YC Paper Club

This Paper Club delves into the current state of robotics, addressing roadblocks like the sim-to-real gap and embodiment drift. Speakers present advancements in multi-scale memory for long-horizon tasks, self-supervised embodied reasoning, zero-shot dexterous manipulation via massive simulation, and the economic imperative of teleoperation-first robotics companies, concluding with optimizations for efficient, real-time World Action Models.

Aug 04, 2026

How AI Helps Solve Medical Mysteries at Boston Children’s Hospital | OpenAI Forum

Researchers from Boston Children's Hospital and OpenAI collaborated to apply AI (specifically, OpenAI o3 Deep Research) to tackle the "diagnostic odyssey" of rare diseases. By analyzing complex genomic and phenotypic data, the AI model helped identify 18 new diagnoses in 376 previously unsolved pediatric cases, showcasing its ability to accelerate literature review, generate hypotheses, and uncover obscure but critical information. This human-in-the-loop approach aims to make diagnosis faster, more accessible, and more precise, offering hope for personalized medicine and improved patient outcomes.

Aug 04, 2026

Chai Discovery's Bitter Lesson: Drug Design Is Another Scaling Problem

Chai Discovery is revolutionizing drug discovery by treating biology as an engineering problem, leveraging AI—particularly diffusion models and the "bitter lesson" of scaling—to design molecules rather than merely discover them. Their approach has boosted antibody design hit rates from 0.1% to 16%, aiming for a "Molecular CAD" suite that collapses discovery timelines from months to days. They partner with pharma, building infrastructure and creating a data flywheel to develop higher-quality, more targeted medicines for previously undruggable diseases.

Aug 04, 2026

What Are Large Database Models? AI for SQL Data

Martin Keen introduces Large Database Models (LDMs), a new AI paradigm that brings advanced analytical capabilities directly into SQL and relational databases. This allows for semantic queries on the 99% of enterprise data traditionally locked away, enabling faster, more secure insights without costly data movement.

Jul 30, 2026

Jeff Dean: The 1% Rule for Building in AI

Jeff Dean discusses the evolution of AI, drawing parallels between Google's past breakthroughs (like fitting search in RAM and the origin of TPUs) and current challenges. He emphasizes that AI is becoming an energy problem, driving the need for specialized inference hardware. Dean highlights 'context engineering' and multi-agent systems as crucial for long-running, complex AI tasks, and offers advice for startups on finding niches where they can outperform larger entities by focusing on specific domains, data, and models. He stresses the importance of clear specifications for agents and 'taste' in problem selection, encouraging founders to question fundamental assumptions and automate the scientific method to build 'AI that builds AI.'